Key result
Routine screening for depression in patients with coronary heart disease is supported by evidence, and treatment with selective serotonin reuptake inhibitors is safe and can improve medical adherence.
Population
Patients with coronary heart disease (CHD)
Design
Review
Authors
Loading...
Supports depression screening and SSRI use in CHD; leaves open need for RCTs to confirm adherence benefits.
Routine screening for depression in patients with CHD is recommended, as SSRIs are safe and can improve both depressive symptoms and adherence to cardiovascular medications.
Bigger et al. (2010) conducted a review in Depression and Coronary Heart Disease. Routine screening and treatment for depression was evaluated. Routine screening for depression in patients with coronary heart disease is supported by evidence, and treatment with selective serotonin reuptake inhibitors is safe and can improve medical adherence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: